News

UPPSALA, Sweden, September 19, 2023 (GLOBE NEWSWIRE) – Olink Holding AB (publ) (Nasdaq: OLK) today announced the introduction of Olink® Target ...

A team from Genentech leveraged samples from a clinical trial of the anti-IL6R drug tocilizumab in severe COVID-19 ...

Press Release: Eurofins Genomics adopts Olink® technology to advance proteomics research and accelerate precision medicine programs

A group from Boston Children's Hospital used plasma proteomics to identify several IL-17 family cytokines as diagnostic markers ...

A study investigating the associations between circulating inflammatory proteins and neurological outcomes measured baseline proteomics in subjects who were followed ...

A large proteogenomics study into the genetic influences on inflammation-related proteins has provided important insights into the pathogenesis of ...

Leveraging Olink® panels to investigate samples from a phase I clinical trial for combined vaccine and viral latency-reversal therapy ...

A Multiple Sclerosis Disease Activity (MSDA) panel, based on Olink® Proximity Extension Assay (PEA) technology has been clinically validated as ...

Blood proteome profiling of 1400 patients presenting with 12 common types of cancer enabled machine learning derivation of a single ...